| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 20.16M | — |
| Operating expense | — | — |
| Net income | -46.71M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, DNA returned -44.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -16.2% |
| 1 year | -44.5% |
| 5 years | -98.3% |
| All-time high | $552.80 (Oct 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in DNA would be worth today ›No. Ginkgo Bioworks Holdings, Inc. has not paid a dividend in the past 12 months.
Ginkgo Bioworks Holdings, Inc. stock trades on NYSE under the ticker symbol DNA.
Ginkgo Bioworks Holdings, Inc. is part of the Healthcare sector.
Ginkgo Bioworks Holdings, Inc. has a market cap of 468.69M USD, based on the latest quote.
Ginkgo Bioworks Holdings, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
